Literature DB >> 18266274

Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.

Kylie M Quinn1, Fenella J Rich, Lisa M Goldsack, Geoffrey W de Lisle, Bryce M Buddle, Brett Delahunt, Joanna R Kirman.   

Abstract

CD4(+)CD25(+) natural T regulatory cells (Tregs) have been shown to suppress protective immune responses in several different vaccination models. Since the effect of Tregs on vaccination against tuberculosis (Tb) was unknown, we used a murine model to investigate whether natural Tregs suppress the development of protective immunity following Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination. Using a monoclonal antibody against CD25, natural Tregs were inactivated prior to vaccination with BCG. The primary immune response was evaluated after BCG vaccination and the secondary immune response was assessed after an intranasal BCG challenge 42 days after vaccination. Inactivation of natural Tregs prior to vaccination led to an increased immune response 14 days after vaccination, increased numbers of antigen-responsive lymphocytes immediately prior to secondary challenge and the earlier appearance of IFN-gamma-producing CD4(+) and CD8(+) lymphocytes in the draining lymph nodes and lungs after challenge. Despite this, protection from virulent Mycobacterium tuberculosis or M. bovis aerosol challenge was unaffected by natural Treg inactivation prior to BCG vaccination. This suggests that increasing the primary and accelerating the secondary immune responses by inactivating natural Tregs at the time of vaccination, does not affect the development of protective immunity to Tb.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266274     DOI: 10.1002/eji.200737888

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4(+) /CD4(+)  Foxp3(+) cells.

Authors:  Paola Fernanda Fedatto; Cássia Alves Sérgio; Marina Oliveira e Paula; Ana Flávia Gembre; Luís Henrique Franco; Pryscilla Fanini Wowk; Simone Gusmão Ramos; Cynthia Horn; Gilles Marchal; Walter Miguel Turato; Célio Lopes Silva; Denise Morais da Fonseca; Vânia Luiza Deperon Bonato
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

2.  Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen.

Authors:  Shen-An Hwang; Kerry J Welsh; Sydney Boyd; Marian L Kruzel; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2011-11-15       Impact factor: 3.131

3.  Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.

Authors:  Martha Zewdie; Rawleigh Howe; Søren T Hoff; T Mark Doherty; Nahom Getachew; Azeb Tarekegne; Bamlak Tessema; Lawrence Yamuah; Abraham Aseffa; Markos Abebe
Journal:  Tuberculosis (Edinb)       Date:  2016-07-09       Impact factor: 3.131

4.  NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis.

Authors:  Rohan Dhiman; Sivakumar Periasamy; Peter F Barnes; Ankita Garg Jaiswal; Padmaja Paidipally; Amanda B Barnes; Amy Tvinnereim; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

5.  Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells.

Authors:  Carla Palma; Silvia Vendetti; Antonio Cassone
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

6.  Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.

Authors:  Marcela I Henao-Tamayo; Andres Obregón-Henao; Kimberly Arnett; Crystal A Shanley; Brendan Podell; Ian M Orme; Diane J Ordway
Journal:  J Leukoc Biol       Date:  2015-11-20       Impact factor: 4.962

Review 7.  T cells in mycobacterial infection and disease.

Authors:  Andrea M Cooper
Journal:  Curr Opin Immunol       Date:  2009-07-29       Impact factor: 7.486

8.  IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization.

Authors:  Yanping Luo; Xingming Ma; Xun Liu; Xiaoling Lu; Hongxia Niu; Hongjuan Yu; Chunxiang Bai; Jinxiu Peng; Qiaoyang Xian; Yong Wang; Bingdong Zhu
Journal:  Int Immunol       Date:  2015-10-31       Impact factor: 4.823

9.  Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities.

Authors:  Tracy J Ruckwardt; Kathryn L Bonaparte; Martha C Nason; Barney S Graham
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

Review 10.  T cell-mediated host immune defenses in the lung.

Authors:  Kong Chen; Jay K Kolls
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.